PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT

PharmaCyte Biotech (PMCB) Total Current Liabilities (2011 - 2026)

Updated

PharmaCyte Biotech's Total Current Liabilities came in at $768,682 for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 27.5% from $1.06 million a year earlier and down 7.0% from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Total Current Liabilities (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Total Current Liabilities was $826,424, down 71.6% from FY2025.

  • Total Current Liabilities carries a five-year compound annual growth rate of 2.7% (FY2021 to FY2026).
  • Going back by fiscal year, Total Current Liabilities was $2.91 million in FY2025 (-60.7%), $7.42 million in FY2024, $586,581 in FY2023 (-16.7%) and $704,370 in FY2022 (-2.8%).
  • The fiscal Q1 2027 figure represents the lowest quarterly Total Current Liabilities since fiscal Q4 2023.
  • Year-over-year, Total Current Liabilities increased in 1 of the last eight quarters, with an average decline of 45.6%.
  • The fastest year-over-year change in Total Current Liabilities over five years came in fiscal Q3 2024 (growth of 810.7%), and the weakest in fiscal Q1 2026 (a decline of 85.8%).
  • Business Quant data shows PMCB's Total Current Liabilities at $826,424 (Q4 2026), $1.68 million (Q3 2026) and $1.58 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 54.90 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 41.64 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -31.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.02 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.94 Bn
10 PharmaCyte Biotech 4.40 Mn 4.40 Mn - 768,682.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 768,682.00
Apr 30, 2026 826,424.00
Jan 31, 2026 1.68 Mn
Oct 31, 2025 1.58 Mn
Jul 31, 2025 1.06 Mn
Apr 30, 2025 2.91 Mn
Jan 31, 2025 1.19 Mn
Oct 31, 2024 4.78 Mn
Jul 31, 2024 7.47 Mn
Apr 30, 2024 7.42 Mn
Jan 31, 2024 7.54 Mn
Oct 31, 2023 5.24 Mn
Jul 31, 2023 1.52 Mn
Apr 30, 2023 586,581.00
Jan 31, 2023 827,834.00
Oct 31, 2022 1.31 Mn
Jul 31, 2022 1.09 Mn
Apr 30, 2022 704,370.00
Jan 31, 2022 612,976.00
Oct 31, 2021 186,122.00
API Access

PharmaCyte Biotech Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PMCB&period=max&api_key=YOUR_API_KEY